|
Volumn 1, Issue 2, 2006, Pages 131-142
|
Treatment of Alzheimer's disease across the spectrum of severity.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIDEPRESSANT AGENT;
CHOLINESTERASE INHIBITOR;
AGED;
AGING;
ALZHEIMER DISEASE;
COST BENEFIT ANALYSIS;
DISEASE COURSE;
HOSPITALIZATION;
HUMAN;
NEUROPSYCHOLOGICAL TEST;
PATHOPHYSIOLOGY;
REVIEW;
AGED;
AGING;
ALZHEIMER DISEASE;
ANTIDEPRESSIVE AGENTS;
CHOLINESTERASE INHIBITORS;
COST-BENEFIT ANALYSIS;
DISEASE PROGRESSION;
HUMANS;
NEUROPSYCHOLOGICAL TESTS;
SEVERITY OF ILLNESS INDEX;
|
EID: 34547760490
PISSN: 11769092
EISSN: None
Source Type: Journal
DOI: 10.2147/ciia.2006.1.2.131 Document Type: Review |
Times cited : (35)
|
References (63)
|